Sichuan Kelun Pharmaceutical Co Ltd (002422) - Total Liabilities

Latest as of March 2026: CN¥11.39 Billion CNY ≈ $1.67 Billion USD

Based on the latest financial reports, Sichuan Kelun Pharmaceutical Co Ltd (002422) has total liabilities worth CN¥11.39 Billion CNY (≈ $1.67 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Sichuan Kelun Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.

Sichuan Kelun Pharmaceutical Co Ltd - Total Liabilities Trend (2007–2025)

This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Sichuan Kelun Pharmaceutical Co Ltd (002422) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Sichuan Kelun Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Sichuan Kelun Pharmaceutical Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
China Communications Construction Co Ltd
SHG:601800
China CN¥1.59 Trillion
Yangzijiang Shipbuilding (Holdings) Ltd
F:B8O
Germany €26.08 Billion
Insurance Australia Group Limited
F:NRM
Germany €18.52 Billion
Crane Company
NYSE:CR
USA $1.95 Billion
Sociedad Química y Minera de Chile S.A.
SN:SQM-B
Chile CL$6.19 Billion
Samsung SDS Co Ltd
KO:018260
Korea ₩3.25 Trillion
Akzo Nobel NV
AS:AKZA
Netherlands €9.13 Billion
Harmony Gold Mining Company Ltd
BA:HMY
Argentina AR$22.85 Billion

Liability Composition Analysis (2007–2025)

This chart breaks down Sichuan Kelun Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sichuan Kelun Pharmaceutical Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.11 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.46 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sichuan Kelun Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual total liabilities of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥10.54 Billion
≈ $1.54 Billion
-0.35%
2024-12-31 CN¥10.58 Billion
≈ $1.55 Billion
-21.29%
2023-12-31 CN¥13.44 Billion
≈ $1.97 Billion
-22.47%
2022-12-31 CN¥17.33 Billion
≈ $2.54 Billion
-0.43%
2021-12-31 CN¥17.41 Billion
≈ $2.55 Billion
-3.31%
2020-12-31 CN¥18.01 Billion
≈ $2.63 Billion
+2.43%
2019-12-31 CN¥17.58 Billion
≈ $2.57 Billion
+7.21%
2018-12-31 CN¥16.40 Billion
≈ $2.40 Billion
+2.44%
2017-12-31 CN¥16.01 Billion
≈ $2.34 Billion
+34.01%
2016-12-31 CN¥11.94 Billion
≈ $1.75 Billion
+4.59%
2015-12-31 CN¥11.42 Billion
≈ $1.67 Billion
+11.60%
2014-12-31 CN¥10.23 Billion
≈ $1.50 Billion
+29.15%
2013-12-31 CN¥7.92 Billion
≈ $1.16 Billion
+35.05%
2012-12-31 CN¥5.87 Billion
≈ $858.48 Million
+131.48%
2011-12-31 CN¥2.53 Billion
≈ $370.86 Million
+43.16%
2010-12-31 CN¥1.77 Billion
≈ $259.05 Million
+0.93%
2009-12-31 CN¥1.75 Billion
≈ $256.66 Million
+19.65%
2008-12-31 CN¥1.47 Billion
≈ $214.51 Million
+33.75%
2007-12-31 CN¥1.10 Billion
≈ $160.38 Million
--

About Sichuan Kelun Pharmaceutical Co Ltd

SHE:002422 China Drug Manufacturers - General
Market Cap
$10.45 Billion
CN¥71.44 Billion CNY
Market Cap Rank
#2145 Global
#223 in China
Share Price
CN¥44.91
Change (1 day)
-10.00%
52-Week Range
CN¥28.83 - CN¥49.90
All Time High
CN¥49.90
About

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, ve… Read more